Giang Thi Hang Phan

Dr. Giang Thi Hang Phan

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 December 2024 in Microorganisms
Verified
Journal Article
Open access
PDF file
MBMarco Bo
Marco Bo
ACALESSANDRA CARTA
ALESSANDRA CARTA
CCChiara Cipriani
Chiara Cipriani
VCVanna Cavassa
Vanna Cavassa
ESElena Rita Simula
Elena Rita Simula
Leonardo SechiLeonardo Sechi
Leonardo Sechi
Increasing evidence indicates that human endogenous retroviruses (HERVs) are important to human health and are an underexplored component of many diseases. Certain HERV families show unique expression patterns and immune responses in autism spectrum disorder (ASD) patients compared to healthy controls, suggesting their potential as biomarkers. Despite these interesting findings, the role of HERVs in ASD needs to be further investigated. In this review, we discuss recent advances in genetic research on ASD, with a particular emphasis on the implications of HERVs on neurodevelopment and future genomic initiatives aimed at discovering ASD-related genes through Artificial Intelligence. Given their pro-inflammatory and autoimmune characteristics, the existing literature suggests that HERVs may contribute to the onset or worsening of ASD in individuals with a genetic predisposition. Therefore, we propose that investigating their fundamental properties could not only improve existing therapies but also pave the way for new therapeutic strategies.

31 August 2026 in Biomedical Research and Therapy
Verified
Journal Article
Open access
PDF file
GPGiang Thi Hang Phan
Giang Thi Hang Phan
LTLoan Thanh Tran
Loan Thanh Tran
TTTuyet-Ngoc Thi Tran
Tuyet-Ngoc Thi Tran
PDPhong-Son Dinh
Phong-Son Dinh
ATAi-Nhi Thi Tran
Ai-Nhi Thi Tran
XHXuan-Dung Ho
Xuan-Dung Ho
Background: Human endogenous retrovirus K (HERV-K, HML-2) is among the most transcriptionally active endogenous retroviral families and has been implicated in breast cancer (BC) pathogenesis. This study aimed to explore HERV-K (HML-2)-associated env expression and evaluate its utility as a potential non-invasive circulating biomarker for BC. Methods: Public RNA-seq data from breast epithelial transformation models (GSE84275) were screened to identify dysregulated HERV-K (HML-2)-associated env signals. An upregulated HERV-K (HML-2)-associated env signal overlapping the chromosome 4p16.1 region was prioritized for clinical evaluation. Peripheral family-level HERV-K (HML-2)-associated env expression was subsequently quantified by quantitative real-time PCR (qRT-PCR) in peripheral blood leukocytes obtained from 56 BC patients and 45 healthy controls. Results: Peripheral HERV-K (HML-2)-associated env expression was significantly higher in BC patients than in healthy controls (median: 0.9111 vs. 0.5284, P = 0.0003). Receiver operating characteristic (ROC) curve analysis demonstrated moderate discriminatory performance (area under the curve [AUC] = 0.7075, 95% CI: 0.6051–0.8100, P = 0.0005). Expression levels were significantly elevated in early-stage disease (stages I–IIA) compared with advanced stages (P < 0.0001). Multivariable logistic regression analysis confirmed that elevated env-associated expression remained an independent predictor of BC (adjusted OR = 12.66, 95% CI: 3.14–51.02, P < 0.001). Conclusions: Elevated peripheral HERV-K (HML-2)-associated env expression represents a circulating molecular signal prominently associated with early-stage breast cancer, highlighting its potential utility as a complementary non-invasive diagnostic biomarker.